<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><condition>metastatic colorectal cancer</condition><disease>Metastatic Colorectal Cancer</disease><study_type>Other</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2637433</full_dataset_link><location>Japan</location><study_start_month>5</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: a retrospective study(WJOG4407GSS)</name><description>Primary outcome(s): Correlation between morphologic response and progression-free survival</description><dates><creation>2016-05-15</creation></dates><accession>2637433</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000022171</Japan Primary Registries Network></cross_references></HashMap>